Karmanos Cancer Center; Department of Oncology

Detroit, Michigan 48201

0 studies enrolling now · 2 studies all time

What they study most

HER2-Negative Metastatic Breast Cancer, HER2-Positive Metastatic Breast Cancer, Locally Advanced or Early Breast Cancer, Non-Small Cell Lung Cancer

Studies at this site

• A Phase 1b Study of Atezolizumab in Combination With Erlotinib or Alectinib in Participants With Non-Small Cell Lung Cancer (NSCLC) — Completed
• Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer — Completed